| Date Filed | Type | Description |
| 08/16/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in Delcath Systems, Inc. |
| 08/11/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 8.2% stake in Axogen, Inc. |
| 07/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in Verastem, Inc. |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/22/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in RIGEL PHARMACEUTICALS INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 14% stake in EDAP TMS S.A. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 0% stake in APOLLO ENDOSURGERY, INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 9.9% stake in CELCUITY INC. |
| 01/30/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.7% stake in JASPER THERAPEUTICS, INC. |
| 01/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 01/26/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 1.3% stake in PIERIS PHARMACEUTICALS, INC. |
| 11/14/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 10% stake in THERATECHNOLOGIES, INC. |
| 10/13/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in Organogenesis Holdings Inc. |
| 09/28/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 13.4% stake in EDAP TMS S.A. |
| 09/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/18/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 9.4% stake in EDAP TMS S.A. |
| 02/10/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 9.6% stake in THERATECHNOLOGIES, INC. |
| 02/10/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 5.8% stake in APOLLO ENDOSURGERY, INC. |
| 01/27/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 12/20/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/23/2021 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 7.8% stake in THERATECHNOLOGIES, INC. |